ID   BHMT1_RAT               Reviewed;         407 AA.
AC   O09171; Q6AZ06;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   02-OCT-2024, entry version 158.
DE   RecName: Full=Betaine--homocysteine S-methyltransferase 1 {ECO:0000303|PubMed:12487625};
DE            EC=2.1.1.5 {ECO:0000269|PubMed:12487625, ECO:0000269|PubMed:28288879};
GN   Name=Bhmt {ECO:0000303|PubMed:12487625};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8753772; DOI=10.1006/bbrc.1996.1183;
RA   Forestier M., Reichen J., Solioz M.;
RT   "Application of mRNA differential display to liver cirrhosis: reduced
RT   fetuin expression in biliary cirrhosis in the rat.";
RL   Biochem. Biophys. Res. Commun. 225:377-383(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10417327; DOI=10.1042/bj3410639;
RA   Sowden M.P., Collins H.L., Smith H.C., Garrow T.A., Sparks J.D.,
RA   Sparks C.E.;
RT   "Apolipoprotein B mRNA and lipoprotein secretion are increased in McArdle
RT   RH-7777 cells by expression of betaine-homocysteine S-methyltransferase.";
RL   Biochem. J. 341:639-645(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF GLU-21; ASP-26; THR-73; PHE-74;
RP   TYR-77; ALA-119; GLU-159; THR-184 AND CYS-186.
RX   PubMed=12487625; DOI=10.1042/bj20021510;
RA   Gonzalez B., Campillo N., Garrido F., Gasset M., Sanz-Aparicio J.,
RA   Pajares M.A.;
RT   "Active-site-mutagenesis study of rat liver betaine-homocysteine S-
RT   methyltransferase.";
RL   Biochem. J. 370:945-952(2003).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, SUBUNIT, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF LYS-7; LYS-8; LYS-10 AND ARG-11.
RX   PubMed=28288879; DOI=10.1016/j.bbamcr.2017.03.004;
RA   Perez-Miguelsanz J., Vallecillo N., Garrido F., Reytor E., Perez-Sala D.,
RA   Pajares M.A.;
RT   "Betaine homocysteine S-methyltransferase emerges as a new player of the
RT   nuclear methionine cycle.";
RL   Biochim. Biophys. Acta 1864:1165-1182(2017).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS), AND SUBUNIT.
RX   PubMed=15099744; DOI=10.1016/j.jmb.2004.03.005;
RA   Gonzalez B., Pajares M.A., Martinez-Ripoll M., Blundell T.L.,
RA   Sanz-Aparicio J.;
RT   "Crystal structure of rat liver betaine homocysteine S-methyltransferase
RT   reveals new oligomerization features and conformational changes upon
RT   substrate binding.";
RL   J. Mol. Biol. 338:771-782(2004).
CC   -!- FUNCTION: Involved in the regulation of homocysteine metabolism.
CC       Converts betaine and homocysteine to dimethylglycine and methionine,
CC       respectively. This reaction is also required for the irreversible
CC       oxidation of choline. {ECO:0000269|PubMed:12487625,
CC       ECO:0000269|PubMed:28288879}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycine betaine + L-homocysteine = L-methionine + N,N-
CC         dimethylglycine; Xref=Rhea:RHEA:22336, ChEBI:CHEBI:17750,
CC         ChEBI:CHEBI:57844, ChEBI:CHEBI:58199, ChEBI:CHEBI:58251; EC=2.1.1.5;
CC         Evidence={ECO:0000269|PubMed:12487625, ECO:0000269|PubMed:28288879};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22337;
CC         Evidence={ECO:0000305|PubMed:12487625, ECO:0000305|PubMed:28288879};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion per subunit.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=106.4 uM for L-homocysteine {ECO:0000269|PubMed:12487625};
CC         KM=333.3 uM for glycine betaine {ECO:0000269|PubMed:12487625};
CC         Vmax=18.67 nmol/min/mg enzyme (L-methionine biosynthesis)
CC         {ECO:0000269|PubMed:12487625};
CC   -!- PATHWAY: Amine and polyamine degradation; betaine degradation;
CC       sarcosine from betaine: step 1/2.
CC   -!- PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de novo
CC       pathway; L-methionine from L-homocysteine (BhmT route): step 1/1.
CC       {ECO:0000305|PubMed:12487625}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15099744,
CC       ECO:0000269|PubMed:28288879}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:12487625,
CC       ECO:0000269|PubMed:28288879}. Nucleus {ECO:0000269|PubMed:28288879}.
CC       Note=Predominantly localized in the cytoplasm with a small fraction
CC       detected in the nucleus. Translocates into the nucleus upon oxidative
CC       stress. {ECO:0000269|PubMed:28288879}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver and kidney (at protein
CC       level). Expressed at lower levels in testis, lung, cerebellum, skeletal
CC       muscle and pancreas (at protein level). {ECO:0000269|PubMed:28288879}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U96133; AAB53763.1; -; mRNA.
DR   EMBL; AF038870; AAB95481.1; -; mRNA.
DR   EMBL; BC078811; AAH78811.1; -; mRNA.
DR   RefSeq; NP_110477.1; NM_030850.1.
DR   PDB; 1UMY; X-ray; 2.50 A; A/B/C/D=1-407.
DR   PDBsum; 1UMY; -.
DR   AlphaFoldDB; O09171; -.
DR   SMR; O09171; -.
DR   IntAct; O09171; 2.
DR   STRING; 10116.ENSRNOP00000015336; -.
DR   iPTMnet; O09171; -.
DR   PhosphoSitePlus; O09171; -.
DR   PaxDb; 10116-ENSRNOP00000015336; -.
DR   GeneID; 81508; -.
DR   KEGG; rno:81508; -.
DR   UCSC; RGD:621496; rat.
DR   AGR; RGD:621496; -.
DR   CTD; 635; -.
DR   RGD; 621496; Bhmt.
DR   eggNOG; KOG1579; Eukaryota.
DR   InParanoid; O09171; -.
DR   OrthoDB; 66796at2759; -.
DR   PhylomeDB; O09171; -.
DR   TreeFam; TF329202; -.
DR   BioCyc; MetaCyc:MONOMER-9241; -.
DR   BRENDA; 2.1.1.10; 5301.
DR   BRENDA; 2.1.1.5; 5301.
DR   Reactome; R-RNO-1614635; Sulfur amino acid metabolism.
DR   Reactome; R-RNO-6798163; Choline catabolism.
DR   UniPathway; UPA00051; UER00083.
DR   UniPathway; UPA00291; UER00432.
DR   EvolutionaryTrace; O09171; -.
DR   PRO; PR:O09171; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0047150; F:betaine-homocysteine S-methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0008168; F:methyltransferase activity; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0071266; P:'de novo' L-methionine biosynthetic process; ISO:RGD.
DR   GO; GO:0006579; P:amino-acid betaine catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006577; P:amino-acid betaine metabolic process; ISO:RGD.
DR   GO; GO:0071267; P:L-methionine salvage; ISO:RGD.
DR   GO; GO:0009086; P:methionine biosynthetic process; IDA:RGD.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   Gene3D; 3.20.20.330; Homocysteine-binding-like domain; 1.
DR   InterPro; IPR017226; Betaine-hCys_S-MeTrfase_BHMT.
DR   InterPro; IPR051524; BHMT.
DR   InterPro; IPR003726; HCY_dom.
DR   InterPro; IPR036589; HCY_dom_sf.
DR   PANTHER; PTHR46120; BETAINE--HOMOCYSTEINE S-METHYLTRANSFERASE 1; 1.
DR   PANTHER; PTHR46120:SF2; BETAINE--HOMOCYSTEINE S-METHYLTRANSFERASE 1; 1.
DR   Pfam; PF02574; S-methyl_trans; 1.
DR   PIRSF; PIRSF037505; Betaine_HMT; 1.
DR   SUPFAM; SSF82282; Homocysteine S-methyltransferase; 1.
DR   PROSITE; PS50970; HCY; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Metal-binding; Methyltransferase; Nucleus;
KW   Phosphoprotein; Reference proteome; Transferase; Zinc.
FT   CHAIN           1..407
FT                   /note="Betaine--homocysteine S-methyltransferase 1"
FT                   /id="PRO_0000114624"
FT   DOMAIN          11..314
FT                   /note="Hcy-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00333"
FT   BINDING         217
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q93088,
FT                   ECO:0000255|PROSITE-ProRule:PRU00333"
FT   BINDING         299
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q93088,
FT                   ECO:0000255|PROSITE-ProRule:PRU00333"
FT   BINDING         300
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q93088,
FT                   ECO:0000255|PROSITE-ProRule:PRU00333"
FT   MOD_RES         40
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35490"
FT   MOD_RES         93
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35490"
FT   MOD_RES         98
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35490"
FT   MOD_RES         232
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35490"
FT   MOD_RES         241
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35490"
FT   MOD_RES         330
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         340
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35490"
FT   MOD_RES         377
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35490"
FT   MUTAGEN         7
FT                   /note="K->A: Has no effect on tetramer assembly or
FT                   catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:28288879"
FT   MUTAGEN         8
FT                   /note="K->A: Has no effect on tetramer assembly. Decreases
FT                   the catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:28288879"
FT   MUTAGEN         10
FT                   /note="K->A: Has no effect on tetramer assembly. Decreases
FT                   the catalytic efficiency. Alters nucleocytoplasmic
FT                   distribution."
FT                   /evidence="ECO:0000269|PubMed:28288879"
FT   MUTAGEN         11
FT                   /note="R->A: Has no effect on tetramer assembly."
FT                   /evidence="ECO:0000269|PubMed:28288879"
FT   MUTAGEN         21
FT                   /note="E->A,K: Decreases the catalytic efficiency.
FT                   Increases the affinity for L-homocysteine."
FT                   /evidence="ECO:0000269|PubMed:12487625"
FT   MUTAGEN         26
FT                   /note="D->A,I: Decreases the catalytic efficiency.
FT                   Decreases the affinity for glycine betaine."
FT                   /evidence="ECO:0000269|PubMed:12487625"
FT   MUTAGEN         73
FT                   /note="T->G: Decreases the catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:12487625"
FT   MUTAGEN         74
FT                   /note="F->A: Decreases the catalytic efficiency. Decreases
FT                   the affinity for glycine betaine."
FT                   /evidence="ECO:0000269|PubMed:12487625"
FT   MUTAGEN         77
FT                   /note="Y->A: Decreases the catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:12487625"
FT   MUTAGEN         119
FT                   /note="A->G: Decreases the catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:12487625"
FT   MUTAGEN         159
FT                   /note="E->G,K: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:12487625"
FT   MUTAGEN         184
FT                   /note="T->G: Decreases the catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:12487625"
FT   MUTAGEN         186
FT                   /note="C->A,S: Decreases the catalytic efficiency.
FT                   Increases the affinity for L-homocysteine."
FT                   /evidence="ECO:0000269|PubMed:12487625"
FT   CONFLICT        247..248
FT                   /note="HA -> QP (in Ref. 3; AAH78811)"
FT                   /evidence="ECO:0000305"
FT   HELIX           13..18
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           29..35
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   TURN            41..43
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           48..51
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           53..66
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   STRAND          70..72
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           96..112
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   TURN            113..115
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   STRAND          117..122
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           126..129
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           134..150
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   STRAND          154..158
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           164..175
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   STRAND          181..185
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           198..207
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   STRAND          211..219
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           221..236
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   TURN            237..239
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   STRAND          243..247
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           261..263
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   TURN            265..269
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           272..274
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           278..291
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           304..313
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           315..318
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           323..327
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   STRAND          330..332
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           333..335
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           341..344
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           349..354
FT                   /evidence="ECO:0007829|PDB:1UMY"
FT   HELIX           378..397
FT                   /evidence="ECO:0007829|PDB:1UMY"
SQ   SEQUENCE   407 AA;  44976 MW;  36E1D04A8E425887 CRC64;
     MAPIAGKKAK RGILERLNAG EVVIGDGGFV FALEKRGYVK AGPWTPEAAV EHPEAVRQLH
     REFLRAGSNV MQTFTFYASE DKLENRGNYV AEKISGQKVN EAACDIARQV ADEGDALVAG
     GVSQTPSYLS CKSETEVKKI FHQQLEVFMK KNVDFLIAEY FEHVEEAVWA VEALKTSGKP
     IAATMCIGPE GDLHGVSPGE CAVRLVKAGA AIVGVNCHFD PSTSLQTIKL MKEGLEAARL
     KAYLMSHALA YHTPDCGKQG FIDLPEFPFG LEPRVATRWD IQKYAREAYN LGVRYIGGCC
     GFEPYHIRAI AEELAPERGF LPPASEKHGS WGSGLDMHTK PWIRARARKE YWQNLRIASG
     RPYNPSMSKP DAWGVTKGAA ELMQQKEATT EQQLRALFEK QKFKSAQ
//
